SASKATOON, Saskatchewan, Aug 2, 2021 (GLOBE NEWSWIRE) – Mother Labs Inc. (“Mother Labs”) and Rascal Seed Research Laboratories Pty. Limited. (“Rascal Seed”) is pleased to announce that a shipment of tissue culture germplasm has been successfully received in South Africa with Health Canada approval granted earlier this year. The companies have entered into a long-term, multi-year partnership whereby Mother Labs will supply contract genetics, including over ten (10) high quality premium cultivars to the South African Tissue Culture Laboratory and Research Facility.
Rascal Seed has selected premium genetics, cultivars that have 22-30% THC and + 3% terpenes, and are free of verified pests and pathogens, from Mother Lab’s curated inventory of plant material. In addition to this, Mother’s expertise Dynamic Supply & Logistics Labs supports Rascal Seeds research by ensuring global air cargo shipments of these industry-shaping genetics reach their destination safely. Such relationships should help lead the way in the rapidly expanding medical cannabis market in South Africa.
“For Rascal Seed, partnering with Mother Labs, an internationally recognized cannabis breeding and consulting company, to obtain its genetics is a significant step in the direction of producing superior and consistent material suitable for the medical cannabis industry. In partnership with Mother Labs and with our extensive experience in greenhouse culture and tissue culture technology, we also have plans to become an accredited source of trusted cannabis genetics in South Africa. ”- Dawie Ras, CEO of Rascal Seed.
“This successful shipment to South Africa marks a new era in the international cannabis market. Mother Labs is pleased to continue adding value to the international space by leveraging our extensive list of genetic offerings, our industry-leading tissue culture laboratory, and the countless years of cannabis experience our team possesses. This is the first of many successful international deliveries. “- Brian Bain, CEO of Mother Labs.
By providing reliable genetics, Mother Labs’ Biological Asset Management (BAM ™) process should help support the cannabis reforms that are currently sweeping the African continent, where the regulated cannabis industry is projected to be worth up to $ 7.1 billion by 2023.
For media inquiries, please contact Mother Labs Operations Manager Cindy Pinder Cindy@motherlabs.ca or by phone at 306-230-5916.
About Rascal Seed
Founded in 1993, Rascal was the first private company to produce minitubers in South Africa. Rascal is the largest producer of certified generation 0 minitubers in Africa and one of the largest in the world, with a current annual production of more than 7 million minitubers. They have a tissue culture laboratory employing highly experienced staff to ensure maximum productivity combined with strict quality control and sanitation. In addition, they supply tissue culture products in commercial quantities at competitive prices.
About Mother Labs
Mother Labs is a full service cannabis supplier specializing in Biological Asset Management or BAM ™. Mother’s Nursery and Tissue Culture Laboratory is committed to helping the cannabis industry succeed and prosper by providing the resources necessary to bring a healthy supply of premium quality cannabis raw materials and unique genetic profiles to market. The Company’s team specializes in the contractual supply of plant material, cultivation consultations, genetic procurement / supply, genetic remediation and genetic storage. Mother Labs’ proprietary process for growing and developing consistent quality cannabis through innovation helps its clients increase revenue, mitigate risk, and increase the efficiency and overall success of their operations.
This press release includes statements that contain certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward-looking statements are often characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “” “Potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will occur.” These statements are only predictions. Various assumptions were used to draw the conclusions or make the projections contained in the forward-looking statements throughout this press release. Forward-looking statements are based on the opinions and estimates of management as of the date the statements are made and are subject to various risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the statements. prospective. . The Company has no obligation and expressly disclaims any intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as expressly required by applicable law.